URGN Stock-Based Compensation
Urogen Pharma Ltd · Stock-Based Compensation
URGN Stock-Based Compensation
Latest reported$16.12Mperiod ending
URGN Stock-Based Comp ($541.00K → $16.12M)
Annual stock-based compensation
High-resolution chart · PNG
URGN stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 11,959,000 | |
| 13,108,000 | |
| 9,343,000 | |
| 10,580,000 | |
| 23,113,000 | |
| 28,025,000 | |
| 29,967,000 | |
| 30,642,000 | |
| 6,300,000 | |
| 1,967,000 | |
| 449,000 | |
| 293,000 | |
| 541,000 |